Philippe Sauvage insider trades: Nuvation Bio (NUVB) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Philippe reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | NUVB | ↓ Sell | 47,668 | $6.01 | $286K | Direct | Jun 24, 2026 (1d) |
| Jun 17, 2025 | NUVB | ↑ Buy | 7,300 | $1.81 | $13K | Direct | Jun 18, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NUVB insiders
Open-market trades in the last 12 months
About Philippe Sauvage's insider trades
Philippe Sauvage is Chief Financial Officer at Nuvation Bio (NUVB). Since Jun 17, 2025, Philippe has reported 1 open-market purchase worth $13K and 1 sale worth $286K on SEC Form 4. In the last 12 months: 1 sale ($286K).
Their filings also include option exercises (2 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NUVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.